Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00471341 · ClinicalTrials.gov registry record · Phase 4
Effect of Celecoxib on Markers of Vascular Inflammation
A Phase 4 study of Hypertension and Coronary Artery Disease, sponsored by University of Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 75
- Enrollment target
- 2
- Study locations
NCT00471341: Completed Phase 4 study of Hypertension and Coronary Artery Disease, sponsored by University of Florida.
NCT00471341 is a Phase 4 study of Hypertension and Coronary Artery Disease that has completed, run by University of Florida. The registered enrollment target is 75 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00471341, a Phase 4 study of Hypertension and Coronary Artery Disease, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 75 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study involves a drug called celecoxib, which is commonly prescribed for people with arthritis. Arthritis is caused by inflammation of the joints or tissues. Inflammation also occurs in the blood vessels that lead to your heart, and the purpose of this study is to see if celecoxib can reduce the blood vessel inflammation associated with high cholesterol and heart disease.
Conditions Studied
Interventions
- DRUG placebo
- DRUG Celecoxib
Study Locations (2)
Florida
- University of Florida - Gainesville
Texas
- University of Texas Health Science Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2002-07 |
| Est. Completion | 2004-12 |
| Phase | Phase 4 |
What the finished NCT00471341 record still lists
NCT00471341 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Hypertension and Coronary Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT00471341 reports a single indexed study location in Florida, Texas.
Frequently Asked Questions
What is clinical trial NCT00471341 about?
NCT00471341 is a clinical study titled "Effect of Celecoxib on Markers of Vascular Inflammation". This study involves a drug called celecoxib, which is commonly prescribed for people with arthritis. Arthritis is caused by inflammation of the joints or tissues. Inflammation also occurs in the blood vessels that lead to your heart, and the purpose of this study is to see if celecoxib can reduce th...
What is the current status of trial NCT00471341?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2002-07. Estimated completion is 2004-12.
What conditions does trial NCT00471341 study?
This clinical trial studies the following conditions: Hypertension and Coronary Artery Disease.
What interventions are being tested in trial NCT00471341?
The interventions under investigation include: placebo (DRUG), Celecoxib (DRUG).
Who is sponsoring clinical trial NCT00471341?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00471341 being conducted?
This trial has 2 study locations across Florida, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00471341's enrollment target sits among peer trials
75 1002nd of 2000 higher than 975 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia